Glaucoma implant study halted early – results pending
Disease control
Terminated
This study tested a new device called Supraflow, implanted in the eye to help drain fluid and lower pressure in people with open-angle glaucoma. It included 22 adults aged 50 and older whose glaucoma medications were not working well enough. The study was terminated early, so ful…
Phase: NA • Sponsor: Ciliatech • Aim: Disease control
Last updated May 18, 2026 12:04 UTC